⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
accessnewswire.com
NVS
Global CEOs to explore new opportunities in Shanghai
prnewswire.com
NVS
BIIB
Arteriosclerosis Obliterans Market Shows Promising Growth Prospects During the Forecast Period (2026-2036) Amid Evolving Treatment Landscape | DelveInsight
prnewswire.com
LLY
REGN
LSTA
ABT
PFE
JNJ
MRK
BMY
AZN
NVS
AMGN
GILD
BIIB
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
prnewswire.com
NVS
Generic Drug Manufacturing Market Size, Share, Trends, and Forecast 2025-2034 | Patent Expirations and Biosimilars Drive 6.20% CAGR Toward USD 817.99 Billion
globenewswire.com
NVS
PCR Market Report Forecasts qPCR, Digital PCR and Multiplex Testing Growth, Profiling 89 Companies Including Roche and Thermo Fisher
globenewswire.com
TMO
AGNC
QGEN
EXAS
LH
DGX
BNTX
CRSP
REGN
GILD
AMGN
BMY
MRK
PFE
ABBV
LLY
AZN
SNY
NVS
BIIB
VRTX
BMRN
IDXX
CRWD
DDOG
SNOW
NVDA
AMD
INTC
MSFT
QDEL
MYGN
SENS
INM
PRPO
CODX
BFC
BSY
NCL
ABT
DHR
BDX
BIO
BRKR
CTAS
CUE
HOLX
Pheochromocytoma and Paraganglioma (PCPG) Market to Reach US$670 Million by 2036 at 7.3% CAGR, Driven by Targeted and Radioligand Therapies
globenewswire.com
MRK
NVS
JAZZ
BHC
Global Cell & Gene Therapy Market Size and Forecast Report 2026-2036 | Market to Reach US$126.86 Billion at 17.3% CAGR as CRISPR, CAR-T and Scalable Manufacturing Drive Growth
globenewswire.com
ALLO
ATRA
BEAM
BMRN
BMY
CRSP
GILD
INTC
JNJ
NVS
VRTX
Optogenetic therapy is safe and allows blind people to detect objects
globenewswire.com
NVS
Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)
globenewswire.com
NVS